Evidence map›Paper›PMID 35879765›Full record

ArticleCritical care (London, England)2022

Acute kidney injury in critical COVID-19: a multicenter cohort analysis in seven large hospitals in Belgium.

Hannah Schaubroeck, Wim Vandenberghe, Willem Boer, Eva Boonen, Bram Dewulf, Camille Bourgeois, Jasperina Dubois, Alexander Dumoulin, Tom Fivez, Jan Gunst and 8 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Critical care (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04997915 (Acute Kidney Injury in COVID-19 Patients Admitted to the ICU), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04997915 completednot on this map

Acute Kidney Injury in COVID-19 Patients Admitted to the ICU: a Multicenter Cohort Analysis in 9 Large Hospitals in Belgium

TypeobservationalSponsorUniversity Hospital, GhentRan2020 to 2022Enrolled1,286ConditionsCritical Illness, COVID-19 Pneumonia, Acute Kidney InjuryArmsObservational study exploring the epidemiology and outcomes of AKI in critical COVID-19 patients admitted to the ICU
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Observational
  4. Article
  5. Article
  6. COVID-19 associated acute kidney injury.Infectious diseases & immunity · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Kidney Injury in Critically Ill Patients with COVID-19 - From Pathophysiological Mechanisms to a Personalized Therapeutic Model.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Hannah SchaubroeckDepartment of Intensive Care Medicine, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, Corneel Heymanslaan 10, 9000, Ghent, Belgium. Hannah.Schaubroeck@Ugent.Be.ORCID 0000-0002-5219-4834
Wim VandenbergheDepartment of Intensive Care Medicine, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, Corneel Heymanslaan 10, 9000, Ghent, Belgium.ORCID 0000-0001-5464-7940
Willem BoerDepartment of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Medicine, Ziekenhuis Oost Limburg ZOL, Genk, Belgium.ORCID 0000-0002-5010-4567
Eva BoonenDepartment of Intensive Care Medicine, AZ Turnhout, Turnhout, Belgium.ORCID 0000-0003-1431-3940
Bram DewulfDepartment of Anaesthesiology and Critical Care Medicine, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Camille BourgeoisDepartment of Anaesthesiology and Critical Care Medicine, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Jasperina DuboisDepartment of Intensive Care Medicine and Anaesthesiology, Jessa Hospital, Hasselt, Belgium.ORCID 0000-0002-8076-9279
Alexander DumoulinDepartment of Intensive Care Medicine, AZ Delta, Roeselare, Belgium.
Tom FivezDepartment of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Medicine, Ziekenhuis Oost Limburg ZOL, Genk, Belgium.ORCID 0000-0002-3505-1196
Jan GunstDepartment of Intensive Care Medicine, University Hospitals Leuven, Leuven, Belgium.ORCID 0000-0003-2470-6393
Greet HermansLaboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0001-5340-1500
Piet LormansDepartment of Intensive Care Medicine, AZ Delta, Roeselare, Belgium.
Philippe MeerssemanDepartment of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
Dieter MesottenDepartment of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Medicine, Ziekenhuis Oost Limburg ZOL, Genk, Belgium.ORCID 0000-0002-3258-4720
Björn StesselDepartment of Intensive Care Medicine and Anaesthesiology, Jessa Hospital, Hasselt, Belgium.ORCID 0000-0002-1422-2777
Marc VanhoofDepartment of Intensive Care Medicine, AZ Turnhout, Turnhout, Belgium.
Greet De Vlieger *Department of Intensive Care Medicine, University Hospitals Leuven, Leuven, Belgium.ORCID 0000-0002-6579-6965
Eric Hoste *Department of Intensive Care Medicine, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, Corneel Heymanslaan 10, 9000, Ghent, Belgium.ORCID 0000-0001-9301-8055

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) has been reported as a frequent complication of critical COVID-19. We aimed to evaluate the occurrence of AKI and use of kidney replacement therapy (KRT) in critical COVID-19, to assess patient and kidney outcomes and risk factors for AKI and differences in outcome when the diagnosis of AKI is based on urine output (UO) or on serum creatinine (sCr).

methodsMulticenter, retrospective cohort analysis of patients with critical COVID-19 in seven large hospitals in Belgium. AKI was defined according to KDIGO within 21 days after ICU admission. Multivariable logistic regression analysis was used to explore the risk factors for developing AKI and to assess the association between AKI and ICU mortality.

resultsOf 1286 patients, 85.1% had AKI, and KRT was used in 9.8%. Older age, obesity, a higher APACHE II score and use of mechanical ventilation at day 1 of ICU stay were associated with an increased risk for AKI. After multivariable adjustment, all AKI stages were associated with ICU mortality. AKI was based on sCr in 40.1% and UO in 81.5% of patients. All AKI stages based on sCr and AKI stage 3 based on UO were associated with ICU mortality. Persistent AKI was present in 88.6% and acute kidney disease (AKD) in 87.6%. Rapid reversal of AKI yielded a better prognosis compared to persistent AKI and AKD. Kidney recovery was observed in 47.4% of surviving AKI patients.

conclusionsOver 80% of critically ill COVID-19 patients had AKI. This was driven by the high occurrence rate of AKI defined by UO criteria. All AKI stages were associated with mortality (NCT04997915).

Indexed as

Acute Kidney InjuryCOVID-19BelgiumCohort StudiesCritical IllnessHospitalsHumansIntensive Care UnitsRetrospective StudiesAcute kidney injuryCOVID-19EpidemiologyIntensive care unitKDIGOKidney replacement therapyMortalityRenal replacement therapySerum creatinineUrine output

Identifiers

PMID35879765
PMCPMC9310674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.